AgingResearch.NewsJoin free

Janus graphene oxide loaded with fenofibrate

Intervention

1 paper2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Funders: Key Technologies Research and Development Program and 2 more
  • Animals1

Outcomes

2

Inflammation

downin rats1

1 study

  1. Janus graphene oxide loaded with fenofibrate decreases inflammation in rats.

    “mitigated inflammation, promoted matrix regeneration, and restored innate lubrication.”

    Animalsin osteoarthritiscartilage

    Janus Graphene Oxide Nanoplatform with Oppositely Functionalized Adhesion and Lubrication Enables Local Sustained Fenofibrate Release to Synergistically Halt Osteoarthritis

    Advanced materials (Deerfield Beach, Fla.)16 Oct 2025

More on Inflammation

Cartilage degradation

downin rats1

1 study

  1. Janus graphene oxide loaded with fenofibrate decreases cartilage degradation in rats.

    “validated MGO-FN's potent therapeutic effects, including reduced cartilage degradation, mitigated inflammation, promoted matrix regeneration, and restored innate lubrication.”

    Animalsin osteoarthritiscartilage

    Janus Graphene Oxide Nanoplatform with Oppositely Functionalized Adhesion and Lubrication Enables Local Sustained Fenofibrate Release to Synergistically Halt Osteoarthritis

    Advanced materials (Deerfield Beach, Fla.)16 Oct 2025

Latest

Related